Skip to main content
LLY
NYSE Life Sciences

FDA Approves Lilly's Once-Weekly Insulin Onswik for Type 2 Diabetes

Tom Rudovsky · Reported by PR Newswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1,148.569
Mkt Cap
$1.083T
52W Low
$712.05
52W High
$1,292.65
52W Position info
61% above low
Off High info
11% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 61% above its 52-week low of $712.05.

Summary

The FDA approved Lilly's Onswik, a once-weekly basal insulin for adults with type 2 diabetes. This is the fourth global approval for the drug, following EMA, Mexico, and Japan. Onswik reduces injections from 365 to 52 per year, a meaningful convenience advantage over daily basal insulins. The approval is based on the QWINT Phase 3 program involving over 3,400 patients, where Onswik met non-inferiority for A1C reduction. Lilly plans a U.S. launch in the coming months with two KwikPen concentrations.

At the time of this announcement, LLY was trading at $1,148.57 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $712.05 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,442.69 info
Change: -$12.67 (-0.87%) info
Market Cap: $1.357T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,442.69 info
Change: -$10.01 (-0.69%) info
Market Cap: $1.357T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,442.69 info
Change: -$5.16 (-0.36%) info
Market Cap: $1.357T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,442.69 info
Change: +$31.57 (+2%) info
Market Cap: $1.357T info
LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,442.69 info
Change: +$48.53 (+3%) info
Market Cap: $1.357T info